Atlas Trials

BRAF v600 Mutated Metastatic Melanoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF v600 Mutated Metastatic Melanoma

RecordFirmDate
Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients (NCT05806268)Novartis Pharmaceuticals2021-07-30

Track BRAF v600 Mutated Metastatic Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.